Cell Line Genetics
How to Send Samples
OUR COMPANY REFERENCES CAREERS CONTACT US
 
Stem Cell Research Services
Cancer Research Services
Custom Services and Products
 
COMPANY NEWS

Dr. Rick Cohen Appointed to CLG's Scientific Advisory Board
Rick Cohen, PhD, Rutgers University assistant research professor at the Keck Center for...


CLG Receives QNBV Designation from Wisconsin Dept. of Commerce
Upon review of Wisconsin's Department of Commerce, Cell Line Genetics (CLG) has been certified as...


Now Offering: Mycoplasma Detection Services
Nested PCR for accuracy, detects the 12 most common strains that contaminate cell lines, and...


8th Annual ISSCR Conference: Booth #629
Cell Line Genetics will be attending the 2010 International Society of Stem Cell Research in San...


View All  

 
Custom Services and Products

Custom Services

In addition to our line of listed services, Cell Line Genetics performs custom services crucial to a research project. From small projects to large, long term relationships, our customers increasingly use GLG in a variety of functions, benefiting from our world-class expertise in Embryonic Stem Cell and Cancer Research.

The result: Less time on infrastructure work, more time on discovery.

Some examples of custom services provided to our clients include:

  • Detection of donor vs. host cells in IHC tissue sections using FISH, which preserves tissue architecture and allows the detection of important signals in specific cell types. 

  • Localization and quantification of transgenes in mouse cells and other species. Protein production resulting from transgenic animals can potentially factor into the result of an experiment and is often unknown to the researcher.

  • Detection of distribution of cell lines in teratomas or teratocarcinomas produced by injection of ES cells into mice. 

  • Characterization of rare or difficult species (Zebrafish)

  • Research Project Consultation

Products

Cell Line Genetics is engaged in the development of standalone probes, probe combinations and other technologies to further assist research clients in the Embryonic Stem Cell and Cancer Research field.

The company has developed strategic relationships with vendors in the research infrastructure space, allowing us to accelerate our time-to-market.